Smithfield Trust’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Hold |
155
| – | – | ﹤0.01% | 962 |
|
|
2025
Q1 | $6K | Hold |
155
| – | – | ﹤0.01% | 939 |
|
|
2024
Q4 | $7K | Hold |
155
| – | – | ﹤0.01% | 926 |
|
|
2024
Q3 | $8K | Hold |
155
| – | – | ﹤0.01% | 872 |
|
|
2024
Q2 | $8K | Hold |
155
| – | – | ﹤0.01% | 851 |
|
|
2024
Q1 | $11K | Hold |
155
| – | – | ﹤0.01% | 819 |
|
|
2023
Q4 | $13K | Hold |
155
| – | – | ﹤0.01% | 783 |
|
|
2023
Q3 | $5K | Hold |
155
| – | – | ﹤0.01% | 900 |
|
|
2023
Q2 | $5K | Hold |
155
| – | – | ﹤0.01% | 919 |
|
|
2023
Q1 | $5K | Hold |
155
| – | – | ﹤0.01% | 887 |
|
|
2022
Q4 | $7K | Hold |
155
| – | – | ﹤0.01% | 832 |
|
|
2022
Q3 | $8K | Hold |
155
| – | – | ﹤0.01% | 808 |
|
|
2022
Q2 | $6K | Hold |
155
| – | – | ﹤0.01% | 919 |
|
|
2022
Q1 | $6K | Hold |
155
| – | – | ﹤0.01% | 939 |
|
|
2021
Q4 | $7K | Hold |
155
| – | – | ﹤0.01% | 918 |
|
|
2021
Q3 | $6K | Hold |
155
| – | – | ﹤0.01% | 963 |
|
|
2021
Q2 | $3K | Hold |
155
| – | – | ﹤0.01% | 1027 |
|
|
2021
Q1 | $4K | Hold |
155
| – | – | ﹤0.01% | 1019 |
|
|
2020
Q4 | $3K | Hold |
155
| – | – | ﹤0.01% | 1028 |
|
|
2020
Q3 | $3K | Buy |
+155
| New | +$3K | ﹤0.01% | 999 |
|